Compare stocks

Dermapharm Holding SE is a pharmaceutical company based in Germany, specializing in the development, production, and commercialization of off-patent branded pharmaceuticals. The company focuses on several key product segments, including dermatological and allergy products, vitamins, and food supplements. Established in 1991, Dermapharm has developed a diversified product portfolio with over 900 marketing authorizations. It operates production facilities in Europe and maintains a strong sales presence in Germany and other European countries. The company's strategic positioning is bolstered by its vertically integrated business model, which enables efficient product development and manufacturing processes.

Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.